Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICG Distribution in Breast Cancer
NCT01993576Phase 2Completed
- Sponsor
- Institut Jules Bordet
- Start
- Jan 2013
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of indocyanine green in breast cancer, sponsored by Institut Jules Bordet. Started Jan 2013; status: completed.
02
Drugs
indocyanine green
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01993576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01993576.